Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) Interest Expenses (2016 - 2025)

Historic Interest Expenses for CNL Healthcare Properties (CHTH) over the last 14 years, with Q3 2025 value amounting to $10.9 million.

  • CNL Healthcare Properties' Interest Expenses fell 510.97% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 328.26%. This contributed to the annual value of $45.9 million for FY2024, which is 951.69% up from last year.
  • According to the latest figures from Q3 2025, CNL Healthcare Properties' Interest Expenses is $10.9 million, which was down 510.97% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, CNL Healthcare Properties' Interest Expenses registered a high of $11.6 million during Q1 2024, and its lowest value of $3.9 million during Q1 2022.
  • For the 5-year period, CNL Healthcare Properties' Interest Expenses averaged around $8.5 million, with its median value being $10.3 million (2023).
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 2825.93% in 2021, then surged by 14990.94% in 2023.
  • CNL Healthcare Properties' Interest Expenses (Quarter) stood at $3.9 million in 2021, then skyrocketed by 81.8% to $7.1 million in 2022, then soared by 57.58% to $11.2 million in 2023, then rose by 0.9% to $11.3 million in 2024, then fell by 3.15% to $10.9 million in 2025.
  • Its Interest Expenses stands at $10.9 million for Q3 2025, versus $11.0 million for Q2 2025 and $11.0 million for Q1 2025.